XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Noncontrolling Interest (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Noncontrolling Interest [Abstract] |
Schedule of Noncontrolling Interest of Stockholders' Equity | The noncontrolling interest (“NCI”) included as a component of consolidated total stockholders’ equity is summarized for the periods indicated as follows: Schedule of Noncontrolling Interest of Stockholders' Equity
|  | March 31, 2024 |
NCI – equity - December 31, 2023 |  | $ | 29,813 |
Net loss attributable to NCI |  |  | (3,300 | )
Impact of subsidiary equity transactions |  |  | 1,734 |
Lucid Diagnostics proceeds from issuance of preferred stock Series A-1 |  |  | 5,670 |
Lucid Diagnostics exchange of preferred stock Series A and Series A-1 |  |  | (24,295 | )
Lucid Diagnostics proceeds from issuance of preferred stock Series B |  |  | 44,285 |
Lucid Diagnostics deemed dividend on preferred stock |  |  | (7,495 | )
Lucid Diagnostics 2018 Equity Plan stock option exercise |  |  | 4 |
Lucid Diagnostics Employee Stock Purchase Plan Purchase |  |  | 353 |
Conversion of Lucid Diagnostics common stock for Senior Secured Convertible Debt |  |  | 687 |
Stock-based compensation expense - Lucid Diagnostics 2018 Equity Plan |  |  | 744 |
Stock-based compensation expense - Veris Health 2021 Equity Plan |  |  | 5 |
NCI – equity - March 31, 2024 |  | $ | 48,205 |
Schedule of Net Loss Attributable to Common Stockholders | Schedule of Net Loss Attributable to Common Stockholders
Series B Convertible Preferred Stock Issuance and Series A/A-1 Exchange Offer |  | March 13, 2024 |
Fair Value - 44,285 shares of Series B Preferred Stock issued |  | $ | 44,285 |
Less: Fair value related to newly issued Series B Preferred Stock (of 12,495 shares) |  |  | (12,495 | )
Less: Carrying value related to Series A and Series A-1 Preferred Stock Exchanged for Series B Preferred Stock (of 24,295 shares) |  |  | (24,295 | )
Deemed Dividend Charged to Accumulated Deficit |  | $ | 7,495 |

X
- Definition Schedule Of Net Loss Attributable To Common Stockholders [Table Text Block] + References No definition available. + Details
Name: | PAVM_ScheduleOfNetLossAttributableToCommonStockholdersTableTextBlock
Namespace Prefix: | PAVM_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of noncontrolling interest of stockholders equity [Table Text Block] + References No definition available. + Details
Name: | PAVM_ScheduleOfNoncontrollingInterestOfStockholdersEquityTableTextBlock
Namespace Prefix: | PAVM_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_NoncontrollingInterestAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration